Clindamycin News and Research

RSS

Antibiotic-resistant MRSA all too common

Researchers in the U.S. say that methicillin-resistant Staphylococcus aureus or MRSA is the most common cause of skin and soft-tissue infections among patients presenting in emergency rooms across the country.

20 Aug 2006

Dodgy Chinese antibiotic kills at least 7

According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.

10 Aug 2006

Chinese antibiotic suspected of being a killer jab

An antibiotic which is suspected to be responsible for three deaths has been banned in China and all stocks have been recalled.

6 Aug 2006

New treatments for common vaginal infection being studied

Whether a two-week regimen using a stainless steel douching device can eradicate the most common vaginal infection is under study at the Medical College of Georgia.

9 May 2005

Researchers make gains in understanding antibiotic resistance

Howard Hughes Medical Institute researchers chiseling away at the problem of antibiotic resistance now have a detailed explanation of how the drugs' main cellular target in bacteria evolves to become resistant to some of these medications.

22 Apr 2005

People could be exposed to antibiotic-resistant bacteria from breathing air from swine feeding facilities

People could be exposed to antibiotic-resistant bacteria from breathing the air from concentrated swine feeding facilities, according to researchers at the Johns Hopkins Bloomberg School of Public Health.

4 Dec 2004

FDA approval of cream to treat bacterial vaginosis

KV Pharmaceutical Company has announced that it has received approval from the United States Food and Drug Administration (FDA) to market Clindesse (clindamycin phosphate) Vaginal Cream, 2%, a single-dose prescription cream therapy indicated to treat bacterial vaginosis ("BV").

3 Dec 2004

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

In the first study to directly compare the emergence of antibiotic resistance following topical treatment between two antibiotics routinely prescribed for a common vaginal infection, researchers from the Magee-Womens Research Institute have found antibiotic-resistant bacteria more likely to develop with the drug clindamycin than metronidazole.

1 Nov 2004

New Drug Application for Velac accepted for filing by the FDA

Connetics Corporation, a specialty pharmaceutical company focused on dermatology, today announced that the U.S. Food and Drug Administration has accepted for filing the Company's New Drug Application for Velac

25 Oct 2004

Drug-resistant bacteria increasingly causing infections in healthy people

An emerging form of so-called "flesh-eating bacteria" is caused by a strain that is resistant to standard first-line antibiotics. The same type of bacteria, methicillin-resistant Staphylococcus aureus (MRSA) is causing record numbers of less-serious skin infections in children and also is emerging as a cause of pneumonia, which can be deadly

30 Sep 2004

Severe infections with flesh-eating bacteria are considerably more common than expected

In an EU project covering 11 countries, headed by Lund University in Sweden, it was calculated that some 1,000 cases would be found over an initial 1½-year period. Fully 5,000 were identified.

16 Sep 2004

How to avoid MRSA infection

Staph bacteria are not uncommon in health care settings. In fact, they account for a large number of hospital-related infections each year.

3 Aug 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004